PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM
Clinical trial NCT06066255 · UNKNOWN
Trial details
- NCT number
- NCT06066255
- Sponsor
- Institut Paoli-Calmettes
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-31
- Primary completion
- 2026-03-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.